| 商品名称 | Purevax RCCh |
|---|
| 适用类别 | Veterinary |
|---|
| 治疗领域 | |
|---|
| 通用名/非专利名称 | vaccine against feline viral rhinotracheitis, feline calicivirosis and feline Chlamydophila infections |
|---|
| 活性成分 | attenuated feline rhinotracheitis herpesvirus (FHV F2 strain), inactivated feline calicivirosis antigens (FCV 431 and G1 strains), attenuated Chlamydophila felis (905 strain) |
|---|
| 产品号 | EMEA/V/C/000092 |
|---|
| 患者安全信息 | no |
|---|
| 授权状态 | Withdrawn |
|---|
| ATC编码 | |
|---|
| 是否额外监管 | no |
|---|
| 是否仿制药 | no |
|---|
| 是否生物类似药 | no |
|---|
| 是否附条件批准 | no |
|---|
| 是否特殊情形 | no |
|---|
| 是否加速审评 | no |
|---|
| 是否罕用药 | no |
|---|
| 批准上市日期 | 2005/02/22 |
|---|
| 上市许可持有人/公司名称 | Merial |
|---|
| 兽用药物治疗分组 | Immunologicals for felidae, |
|---|
| 决定日期 | 2014/02/12 |
|---|
| 修订号 | 8 |
|---|
| 适应症 | Active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs and excretion;against Chlamydophila felis infection to reduce clinical signs.Onsets of immunity have been demonstrated 1 week after primary vaccination course for rhinotracheitis, calicivirus and Chlamydophila felis components.The duration of immunity is 1 year after the last (re-)vaccination. |
|---|
| 适用物种 | Cats |
|---|
| 兽用药物ATC编码 | QI06AH |
|---|
| 首次发布日期 | 2014/02/13 |
|---|
| 修订日期 | 2015/01/22 |
|---|
| 产品信息 | https://www.ema.europa.eu/en/documents/product-information/purevax-rcch-epar-product-information_en.pdf |
|---|
| 公共评估报告 | https://www.ema.europa.eu/en/medicines/veterinary/EPAR/purevax-rcch |
|---|